130 related articles for article (PubMed ID: 37948774)
1. Development and validation of a sensitive and simple LC-MS/MS method for simultaneous quantitation of valsartan, sacubitril and sacubitrilat in pediatric population.
Yang Q; Cao P; Lv Y; Peng H; Zhai X
J Pharm Biomed Anal; 2024 Jan; 238():115829. PubMed ID: 37948774
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
Giri P; Joshi V; Giri S; Delvadia P; Jain MR
Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
Ayalasomayajula S; Langenickel T; Pal P; Boggarapu S; Sunkara G
Clin Pharmacokinet; 2017 Dec; 56(12):1461-1478. PubMed ID: 28417439
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC-MS/MS.
Jin Y; He Y; Di X; Fu L; Qi X; Liu R; Zheng L; Wang Y; Zhong H; Wang Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123402. PubMed ID: 35930849
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a reliable and rapid LC-MS/MS method for simultaneous quantification of sacubitril and valsartan in rat plasma and its application to a pharmacokinetic study.
Chunduri RH; Dannana GS
Biomed Chromatogr; 2016 Sep; 30(9):1467-75. PubMed ID: 26876742
[TBL] [Abstract][Full Text] [Related]
6. The concentration of maternal sacubitril/valsartan transferred into human milk is negligible.
Falconi S; Okimi A; Wesley S; Sethi P; Datta P; Krutsch K
Front Public Health; 2024; 12():1389513. PubMed ID: 38841677
[TBL] [Abstract][Full Text] [Related]
7. Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
Ayalasomayajula S; Langenickel T; Pal P; Boggarapu S; Sunkara G
Clin Pharmacokinet; 2018 Jan; 57(1):105-123. PubMed ID: 28527109
[TBL] [Abstract][Full Text] [Related]
8. Synchronized determination of sacubitril and valsartan with some co-administered drugs in human plasma via UPLC-MS/MS method using solid-phase extraction.
Moussa BA; Hashem HMA; Mahrouse MA; Mahmoud ST
Biomed Chromatogr; 2021 Nov; 35(11):e5203. PubMed ID: 34145610
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of sacubitril/valsartan (LCZ696) in patients with mild and moderate hepatic impairment
.
Kulmatycki KM; Langenickel T; Ng WH; Pal P; Zhou W; Lin TH; Rajman I; Chandra P; Sunkara G
Int J Clin Pharmacol Ther; 2017 Sep; 55(9):728-739. PubMed ID: 28737127
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
Vijaykumar C; Kumar YR; Aparna P; Rao PSP
Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients.
He Y; Jin Y; Xue H; Liu R; Zhang M; Liao R; Chen M; Zhou X; He X; Qin M; Li K; Zou H; Gan Y; Wang Z; Zheng L; Zhong H; Fu P
Nephrol Dial Transplant; 2023 Jul; 38(8):1880-1889. PubMed ID: 36787894
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a highly sensitive and robust LC-ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study.
Ramani AV; Sengupta P; Mullangi R
Biomed Chromatogr; 2009 Jun; 23(6):615-22. PubMed ID: 19277959
[TBL] [Abstract][Full Text] [Related]
14. Synchronized determination of the novel heart failure combination therapy containing sacubitril calcium and valsartan by a validated spectrofluorimetric method.
Moussa BA; Hashem HMA; Alphonse Mahrouse M; Mahmoud ST
Spectrochim Acta A Mol Biomol Spectrosc; 2021 May; 253():119613. PubMed ID: 33667887
[TBL] [Abstract][Full Text] [Related]
15. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
Mavis ME; Goksu Gursu G; Ular Cagatay N
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.
Hanpithakpong W; Day NPJ; White NJ; Tarning J
Malar J; 2022 Jun; 21(1):169. PubMed ID: 35659684
[TBL] [Abstract][Full Text] [Related]
17. Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.
Ayalasomayajula SP; Langenickel TH; Jordaan P; Zhou W; Chandra P; Albrecht D; Pal P; Rajman I; Sunkara G
Eur J Clin Pharmacol; 2016 Sep; 72(9):1065-73. PubMed ID: 27230850
[TBL] [Abstract][Full Text] [Related]
18. A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma.
Li H; Wang Y; Jiang Y; Tang Y; Wang J; Zhao L; Gu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):436-42. PubMed ID: 17331816
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects.
Akahori M; Ayalasomayajula S; Langenickel T; Pal P; Zhou W; Sunkara G
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):407-416. PubMed ID: 27324506
[TBL] [Abstract][Full Text] [Related]
20. Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study).
Shaddy R; Canter C; Halnon N; Kochilas L; Rossano J; Bonnet D; Bush C; Zhao Z; Kantor P; Burch M; Chen F
Am Heart J; 2017 Nov; 193():23-34. PubMed ID: 29129252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
